Effectiveness of nicotine gum in preventing lapses in the face of temptation to smoke among non‐daily smokers: a secondary analysis.

Saved in:
Bibliographic Details
Title: Effectiveness of nicotine gum in preventing lapses in the face of temptation to smoke among non‐daily smokers: a secondary analysis.
Authors: Shiffman, Saul (AUTHOR), Ferguson, Stuart G. (AUTHOR), Mao, Jason (AUTHOR), Scholl, Sarah M. (AUTHOR), Hedeker, Donald (AUTHOR), Tindle, Hilary A. (AUTHOR)
Source: Addiction. Nov2020, Vol. 115 Issue 11, p2123-2129. 7p. 2 Charts, 1 Graph.
Subjects: Smoking prevention, Disease relapse prevention, Smoking cessation, Secondary analysis, Treatment effectiveness, Descriptive statistics, Nicotine replacement therapy, Odds ratio, Therapeutics
Geographic Terms: Pennsylvania
Abstract: Background and aims: Non‐daily smokers (NDS) comprise a large fraction of US smokers. Despite little or no dependence, as typically assessed, intermittent smokers (ITS) have difficulty quitting smoking. A randomized clinical trial comparing the effect of nicotine gum with placebo on quitting smoking in non‐daily smokers did not find an effect on overall abstinence. We undertook an analysis to assess whether using nicotine gum versus placebo when tempted to smoke could reduce incidence of lapses in those situations. Design Within a 6‐week randomized, placebo‐controlled clinical trial of nicotine gum, analyses contrasted the outcome of temptation episodes where gum was or was not used. Setting: Smoking cessation research clinic in Pittsburgh, PA, USA. Participants: A total of 255 adult ITS (131 nicotine gum, 124 placebo) seeking help for smoking cessation. Intervention: Nicotine gum (2 mg) versus placebo for up to 8 weeks, with as‐needed dosing instructions. Measurements Outcome was lapsing in temptation episodes, as reported by participants via ecological momentary assessment (EMA). Propensity scores predicting gum use from situational factors (e.g. mood, social setting, smoking cues) served as a control variable. Findings Participants reported 2713 temptation episodes, 46.0% (1248) of which resulted in smoking (lapsing). There was a significant gum use × active treatment interaction (P = 0.0009). Using nicotine gum decreased the odds of lapsing by 55% compared with using placebo [odds ratio (OR) = 0.45; 0.22–0.94]; when gum was not used, the assigned gum condition made no significant difference (OR = 1.53; 0.78–3.01; Bayes factor = 0.14). The nicotine effect was not reliably different when participants were trying to achieve abstinence versus when trying to maintain abstinence (OR = 0.44; 0.10, 2.03; P = 0.294; Bayes factor = 0.11), for men and women (OR = 1.68; 0.58, 4.87; P = 0.343; Bayes factor = 0.10), or for participants with some or no dependence (OR = 0.88; 0.30, 2.59; P = 0.811; Bayes factor = 0.06). Conclusions: When used in response to temptation to smoke, 2 mg nicotine gum can help to prevent lapses among non‐daily smokers. [ABSTRACT FROM AUTHOR]
Copyright of Addiction is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 146320053
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Effectiveness of nicotine gum in preventing lapses in the face of temptation to smoke among non‐daily smokers: a secondary analysis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Shiffman%2C+Saul%22">Shiffman, Saul</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ferguson%2C+Stuart+G%2E%22">Ferguson, Stuart G.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mao%2C+Jason%22">Mao, Jason</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Scholl%2C+Sarah+M%2E%22">Scholl, Sarah M.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hedeker%2C+Donald%22">Hedeker, Donald</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tindle%2C+Hilary+A%2E%22">Tindle, Hilary A.</searchLink> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Addiction%22">Addiction</searchLink>. Nov2020, Vol. 115 Issue 11, p2123-2129. 7p. 2 Charts, 1 Graph.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Smoking+prevention%22">Smoking prevention</searchLink><br /><searchLink fieldCode="DE" term="%22Disease+relapse+prevention%22">Disease relapse prevention</searchLink><br /><searchLink fieldCode="DE" term="%22Smoking+cessation%22">Smoking cessation</searchLink><br /><searchLink fieldCode="DE" term="%22Secondary+analysis%22">Secondary analysis</searchLink><br /><searchLink fieldCode="DE" term="%22Treatment+effectiveness%22">Treatment effectiveness</searchLink><br /><searchLink fieldCode="DE" term="%22Descriptive+statistics%22">Descriptive statistics</searchLink><br /><searchLink fieldCode="DE" term="%22Nicotine+replacement+therapy%22">Nicotine replacement therapy</searchLink><br /><searchLink fieldCode="DE" term="%22Odds+ratio%22">Odds ratio</searchLink><br /><searchLink fieldCode="DE" term="%22Therapeutics%22">Therapeutics</searchLink>
– Name: SubjectGeographic
  Label: Geographic Terms
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Pennsylvania%22">Pennsylvania</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Background and aims: Non‐daily smokers (NDS) comprise a large fraction of US smokers. Despite little or no dependence, as typically assessed, intermittent smokers (ITS) have difficulty quitting smoking. A randomized clinical trial comparing the effect of nicotine gum with placebo on quitting smoking in non‐daily smokers did not find an effect on overall abstinence. We undertook an analysis to assess whether using nicotine gum versus placebo when tempted to smoke could reduce incidence of lapses in those situations. Design Within a 6‐week randomized, placebo‐controlled clinical trial of nicotine gum, analyses contrasted the outcome of temptation episodes where gum was or was not used. Setting: Smoking cessation research clinic in Pittsburgh, PA, USA. Participants: A total of 255 adult ITS (131 nicotine gum, 124 placebo) seeking help for smoking cessation. Intervention: Nicotine gum (2 mg) versus placebo for up to 8 weeks, with as‐needed dosing instructions. Measurements Outcome was lapsing in temptation episodes, as reported by participants via ecological momentary assessment (EMA). Propensity scores predicting gum use from situational factors (e.g. mood, social setting, smoking cues) served as a control variable. Findings Participants reported 2713 temptation episodes, 46.0% (1248) of which resulted in smoking (lapsing). There was a significant gum use × active treatment interaction (P = 0.0009). Using nicotine gum decreased the odds of lapsing by 55% compared with using placebo [odds ratio (OR) = 0.45; 0.22–0.94]; when gum was not used, the assigned gum condition made no significant difference (OR = 1.53; 0.78–3.01; Bayes factor = 0.14). The nicotine effect was not reliably different when participants were trying to achieve abstinence versus when trying to maintain abstinence (OR = 0.44; 0.10, 2.03; P = 0.294; Bayes factor = 0.11), for men and women (OR = 1.68; 0.58, 4.87; P = 0.343; Bayes factor = 0.10), or for participants with some or no dependence (OR = 0.88; 0.30, 2.59; P = 0.811; Bayes factor = 0.06). Conclusions: When used in response to temptation to smoke, 2 mg nicotine gum can help to prevent lapses among non‐daily smokers. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Addiction is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=146320053
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/add.15083
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 7
        StartPage: 2123
    Subjects:
      – SubjectFull: Smoking prevention
        Type: general
      – SubjectFull: Disease relapse prevention
        Type: general
      – SubjectFull: Smoking cessation
        Type: general
      – SubjectFull: Secondary analysis
        Type: general
      – SubjectFull: Treatment effectiveness
        Type: general
      – SubjectFull: Descriptive statistics
        Type: general
      – SubjectFull: Nicotine replacement therapy
        Type: general
      – SubjectFull: Odds ratio
        Type: general
      – SubjectFull: Therapeutics
        Type: general
      – SubjectFull: Pennsylvania
        Type: general
    Titles:
      – TitleFull: Effectiveness of nicotine gum in preventing lapses in the face of temptation to smoke among non‐daily smokers: a secondary analysis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Shiffman, Saul
      – PersonEntity:
          Name:
            NameFull: Ferguson, Stuart G.
      – PersonEntity:
          Name:
            NameFull: Mao, Jason
      – PersonEntity:
          Name:
            NameFull: Scholl, Sarah M.
      – PersonEntity:
          Name:
            NameFull: Hedeker, Donald
      – PersonEntity:
          Name:
            NameFull: Tindle, Hilary A.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: Nov2020
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-print
              Value: 09652140
          Numbering:
            – Type: volume
              Value: 115
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: Addiction
              Type: main
ResultId 1